Lenalidomide is a cornerstone therapy for multiple myeloma (MM) and other hematologic malignancies, but conventional oral dosing is limited by high peak plasma concentrations, rapid clearance, and ...

Researchers continue to make rapid advances and discoveries related to genetics and blood cancer. Today, we are directly applying these insights to blood cancer prevention and treatment at the Fred ...

Hematologic malignancies are a heterogeneous group of diseases with unique illness trajectories, treatment paradigms, and potential for curability, which affect patients’ palliative and end-of-life ...

Today, hematology analyzers can collect vast amounts of data about cell characteristics, that subsequently improve disease detection. Advanced systems can perform a complete blood count (CBC) and ...